{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:54:03Z","timestamp":1780098843797,"version":"3.54.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10072-025-08420-3","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T02:29:00Z","timestamp":1756088940000},"page":"5837-5846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical predictors of speech changes after subthalamic neurostimulation in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Francesco","family":"Cavallieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zampogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Castrioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Meoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Gessani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"P\u00e9lissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Valzania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Suppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Chabard\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Fraix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7968-5908","authenticated-orcid":false,"given":"Elena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"8420_CR1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012246","author":"F Bove","year":"2021","unstructured":"Bove F, Mulas D, Cavallieri F, Castrioto A, Chabard\u00e8s S, Meoni S, Schmitt E, Bichon A, Di Stasio E, Kistner A, P\u00e9lissier P, Chevrier E, Seigneuret E, Krack P, Fraix V, Moro E (2021) Long-term outcomes (15 Years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012246","journal-title":"Neurology"},{"key":"8420_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/archneurol.2011.182","volume":"68","author":"A Castrioto","year":"2011","unstructured":"Castrioto A, Lozano AM, Poon Y-Y, Lang AE, Fallis M, Moro E (2011) Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 68:1550\u20131556. https:\/\/doi.org\/10.1001\/archneurol.2011.182","journal-title":"Arch Neurol"},{"key":"8420_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/mds.29066","volume":"37","author":"G Deuschl","year":"2022","unstructured":"Deuschl G, Antonini A, Costa J, \u015ami\u0142owska K, Berg D, Corvol J, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E (2022) European academy of neurology\/movement disorder Society-European section guideline on the treatment of parkinson\u2019s disease: I. Invasive therapies. Mov Disord 37:1360\u20131374. https:\/\/doi.org\/10.1002\/mds.29066","journal-title":"Mov Disord"},{"key":"8420_CR4","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/ene.15386","volume":"29","author":"G Deuschl","year":"2022","unstructured":"Deuschl G, Antonini A, Costa J, \u015ami\u0142owska K, Berg D, Corvol J-C, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E (2022) European academy of neurology\/movement disorder Society - European section guideline on the treatment of parkinson\u2019s disease: I. Invasive therapies. Eur J Neurol 29:2580\u20132595. https:\/\/doi.org\/10.1111\/ene.15386","journal-title":"Eur J Neurol"},{"key":"8420_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00702-017-1676-0","volume":"124","author":"L Brabenec","year":"2017","unstructured":"Brabenec L, Mekyska J, Galaz Z, Rektorova I (2017) Speech disorders in parkinson\u2019s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm (Vienna) 124:303\u2013334. https:\/\/doi.org\/10.1007\/s00702-017-1676-0","journal-title":"J Neural Transm (Vienna)"},{"key":"8420_CR6","doi-asserted-by":"publisher","first-page":"850596","DOI":"10.1155\/2012\/850596","volume":"2012","author":"S Skodda","year":"2012","unstructured":"Skodda S (2012) Effect of deep brain stimulation on speech performance in parkinson\u2019s disease. Parkinsons Dis 2012:850596. https:\/\/doi.org\/10.1155\/2012\/850596","journal-title":"Parkinsons Dis"},{"key":"8420_CR7","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1002\/mds.20962","volume":"14","author":"G Kleiner-Fisman","year":"2006","unstructured":"Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G (2006) Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21 Suppl 14:S290\u2013304. https:\/\/doi.org\/10.1002\/mds.20962","journal-title":"Mov Disord 21 Suppl"},{"key":"8420_CR8","doi-asserted-by":"publisher","unstructured":"Pinto S, Nebel A, Rau J, Espesser R, Maillochon P, Niebuhr O, Krack P, Witjas T, Ghio A, Cuartero M-C, Timmermann L, Schnitzler A, Hesekamp H, Meier N, M\u00fcllner J, H\u00e4lbig TD, M\u00f6ller B, Paschen S, Paschen L, Volkmann J, Barbe MT, Fink GR, Becker J, Reker P, K\u00fchn AA, Schneider G-H, Fraix V, Seigneuret E, Kistner A, Rascol O, Brefel-Courbon C, Ory-Magne F, Hartmann CJ, Wojtecki L, Fradet A, Malt\u00eate D, Damier P, Le Dily S, Sixel-D\u00f6ring F, Benecke P, Weiss D, W\u00e4chter T, Pinsker MO, R\u00e9gis J, Thobois S, Polo G, Houeto J-L, Hartmann A, Knudsen K, Vidailhet M, Sch\u00fcpbach M, Deuschl G (2022) EARLYSTIM Study group, results of a randomized clinical trial of speech after early neurostimulation in parkinson\u2019s disease, Mov Disord https:\/\/doi.org\/10.1002\/mds.29282","DOI":"10.1002\/mds.29282"},{"key":"8420_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1212\/WNL.0b013e318203e7d0","volume":"76","author":"E Tripoliti","year":"2011","unstructured":"Tripoliti E, Zrinzo L, Martinez-Torres I, Frost E, Pinto S, Foltynie T, Holl E, Petersen E, Roughton M, Hariz MI, Limousin P (2011) Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 76:80\u201386. https:\/\/doi.org\/10.1212\/WNL.0b013e318203e7d0","journal-title":"Neurology"},{"key":"8420_CR10","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jnnp-2014-308043","volume":"86","author":"T Tsuboi","year":"2015","unstructured":"Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Yoneyama N, Hara K, Nakamura R, Watanabe H, Senda J, Atsuta N, Ito M, Hirayama M, Yamamoto M, Fujimoto Y, Kajita Y, Wakabayashi T, Sobue G (2015) Distinct phenotypes of speech and voice disorders in parkinson\u2019s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry 86:856\u2013864. https:\/\/doi.org\/10.1136\/jnnp-2014-308043","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8420_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jnnp.2007.117507","volume":"79","author":"G Tommasi","year":"2008","unstructured":"Tommasi G, Krack P, Fraix V, Le Bas J-F, Chabardes S, Benabid A-L, Pollak P (2008) Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 79:813\u2013819. https:\/\/doi.org\/10.1136\/jnnp.2007.117507","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8420_CR12","doi-asserted-by":"publisher","first-page":"105347","DOI":"10.1016\/j.parkreldis.2023.105347","volume":"109","author":"F Lange","year":"2023","unstructured":"Lange F, Eldebakey H, Hilgenberg A, Weigl B, Eckert M, DeSunda A, Neugebauer H, Peach R, Roothans J, Volkmann J, Reich MM (2023) Distinct phenotypes of stimulation-induced dysarthria represent different cortical networks in STN-DBS. Parkinsonism Relat Disord 109:105347. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105347","journal-title":"Parkinsonism Relat Disord"},{"key":"8420_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/mds.20601","volume":"20","author":"S Pinto","year":"2005","unstructured":"Pinto S, Gentil M, Krack P, Sauleau P, Fraix V, Benabid A-L, Pollak P (2005) Changes induced by Levodopa and subthalamic nucleus stimulation on parkinsonian speech. Mov Disord 20:1507\u20131515. https:\/\/doi.org\/10.1002\/mds.20601","journal-title":"Mov Disord"},{"key":"8420_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-333434","author":"H Jergas","year":"2024","unstructured":"Jergas H, Petry-Schmelzer JN, Hannemann JH, Thies T, Strelow JN, Rubi-Fessen I, Quinting J, Baldermann JC, M\u00fccke D, Fink GR, Visser-Vandewalle V, Dembek TA, Barbe MT (2024) One side effect: two networks? Lateral and posteromedial stimulation spreads induce dysarthria in subthalamic deep brain stimulation for parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2024-333434","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8420_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/mds.25816","volume":"29","author":"E Tripoliti","year":"2014","unstructured":"Tripoliti E, Limousin P, Foltynie T, Candelario J, Aviles-Olmos I, Hariz MI, Zrinzo L (2014) Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with parkinson\u2019s disease. Mov Disord 29:532\u2013538. https:\/\/doi.org\/10.1002\/mds.25816","journal-title":"Mov Disord"},{"key":"8420_CR16","doi-asserted-by":"publisher","unstructured":"Swinnen BEKS, Lotfalla V, Scholten MN, Prins RHN, Goes KM, De Vries S, Geytenbeek JJM, Dijk JM, Odekerken VJ, Bot M, Van Den Munckhof P, Schuurman PR, De Bie RMA, Beudel M (2024) Programming algorithm for the management of speech impairment in subthalamic nucleus deep brain stimulation for parkinson\u2019s disease, neuromodulation: technology at the neural interface. 27:528\u2013537. https:\/\/doi.org\/10.1016\/j.neurom.2023.05.002","DOI":"10.1016\/j.neurom.2023.05.002"},{"key":"8420_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.25994","volume":"89","author":"F Cavallieri","year":"2021","unstructured":"Cavallieri F, Fraix V, Bove F, Mulas D, Tondelli M, Castrioto A, Krack P, Meoni S, Schmitt E, Lhomm\u00e9e E, Bichon A, P\u00e9lissier P, Chevrier E, Kistner A, Seigneuret E, Chabard\u00e8s S, Moro E (2021) Predictors of Long-Term outcome of subthalamic stimulation in Parkinson disease. Ann Neurol 89:587\u2013597. https:\/\/doi.org\/10.1002\/ana.25994","journal-title":"Ann Neurol"},{"key":"8420_CR18","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1093\/brain\/awf249","volume":"125","author":"E Moro","year":"2002","unstructured":"Moro E, Esselink RJA, Benabid AL, Pollak P (2002) Response to Levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain 125:2408\u20132417. https:\/\/doi.org\/10.1093\/brain\/awf249","journal-title":"Brain"},{"key":"8420_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1212\/wnl.59.6.932","volume":"59","author":"PD Charles","year":"2002","unstructured":"Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G, Benabid A-L, Pollak P (2002) Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 59:932\u2013934. https:\/\/doi.org\/10.1212\/wnl.59.6.932","journal-title":"Neurology"},{"key":"8420_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24374","volume":"77","author":"M Katz","year":"2015","unstructured":"Katz M, Luciano MS, Carlson K, Luo P, Marks WJ, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL (2015) CSP 468 study group, differential effects of deep brain stimulation target on motor subtypes in parkinson\u2019s disease. Ann Neurol 77:710\u2013719. https:\/\/doi.org\/10.1002\/ana.24374","journal-title":"Ann Neurol"},{"key":"8420_CR21","doi-asserted-by":"publisher","unstructured":"Kluin KJ, Mossner JM, Costello JT, Chou KL, Patil PG (2022) Motor speech effects in subthalamic deep brain stimulation for parkinson\u2019s disease. J Neurosurg 1\u20137. https:\/\/doi.org\/10.3171\/2021.12.JNS211729","DOI":"10.3171\/2021.12.JNS211729"},{"key":"8420_CR22","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1212\/WNL.0000000000009822","volume":"95","author":"F Bove","year":"2020","unstructured":"Bove F, Fraix V, Cavallieri F, Schmitt E, Lhomm\u00e9e E, Bichon A, Meoni S, P\u00e9lissier P, Kistner A, Chevrier E, Ardouin C, Limousin P, Krack P, Benabid AL, Chabard\u00e8s S, Seigneuret E, Castrioto A, Moro E (2020) Dementia and subthalamic deep brain stimulation in Parkinson disease: A long-term overview. Neurology 95:e384\u2013e392. https:\/\/doi.org\/10.1212\/WNL.0000000000009822","journal-title":"Neurology"},{"key":"8420_CR23","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"349","author":"P Krack","year":"2003","unstructured":"Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid A-L, Pollak P (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced parkinson\u2019s disease. N Engl J Med 349:1925\u20131934. https:\/\/doi.org\/10.1056\/NEJMoa035275","journal-title":"N Engl J Med"},{"key":"8420_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","volume":"339","author":"P Limousin","year":"1998","unstructured":"Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Electrical stimulation of the subthalamic nucleus in advanced parkinson\u2019s disease. N Engl J Med 339:1105\u20131111. https:\/\/doi.org\/10.1056\/NEJM199810153391603","journal-title":"N Engl J Med"},{"key":"8420_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0140-6736(95)90062-4","volume":"345","author":"P Limousin","year":"1995","unstructured":"Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91\u201395. https:\/\/doi.org\/10.1016\/s0140-6736(95)90062-4","journal-title":"Lancet"},{"key":"8420_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement disorder society task force on rating scales for parkinson\u2019s disease, movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020\u20131028. https:\/\/doi.org\/10.1002\/mds.20213","journal-title":"Mov Disord"},{"key":"8420_CR27","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement disorder society UPDRS revision task force, movement disorder society-sponsored revision of the unified parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"8420_CR28","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1111\/ene.15436","volume":"29","author":"A Castrioto","year":"2022","unstructured":"Castrioto A, Deb\u00fb B, Cousin E, Pelissier P, Lhomm\u00e9e E, Bichon A, Schmitt E, Kistner A, Meoni S, Seigneuret E, Chabardes S, Krack P, Moro E, Fraix V (2022) Long-term independence and quality of life after subthalamic stimulation in Parkinson disease. Euro J Neurol 29:2645\u20132653. https:\/\/doi.org\/10.1111\/ene.15436","journal-title":"Euro J Neurol"},{"key":"8420_CR29","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.25122","volume":"27","author":"CG Goetz","year":"2012","unstructured":"Goetz CG, Stebbins GT, Tilley BC (2012) Calibration of unified parkinson\u2019s disease rating scale scores to movement disorder Society-unified parkinson\u2019s disease rating scale scores. Mov Disord 27:1239\u20131242. https:\/\/doi.org\/10.1002\/mds.25122","journal-title":"Mov Disord"},{"key":"8420_CR30","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of Levodopa dose equivalency reporting in parkinson\u2019s disease. Mov Disord 25:2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"key":"8420_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified parkinson\u2019s disease rating scale: comparison with the unified parkinson\u2019s disease rating scale. Mov Disord 28:668\u2013670. https:\/\/doi.org\/10.1002\/mds.25383","journal-title":"Mov Disord"},{"key":"8420_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","volume":"8","author":"AL Benabid","year":"2009","unstructured":"Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of parkinson\u2019s disease. Lancet Neurol 8:67\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(08)70291-6","journal-title":"Lancet Neurol"},{"key":"8420_CR33","doi-asserted-by":"publisher","first-page":"11462","DOI":"10.1038\/s41598-023-38555-2","volume":"13","author":"A Gessani","year":"2023","unstructured":"Gessani A, Cavallieri F, Fioravanti V, Campanini I, Merlo A, Di Rauso G, Damiano B, Scaltriti S, Bardi E, Corni MG, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E, Fraternali A, Versari A, Biagini G, Fraix V, Pinto S, Moro E, Budriesi C, Valzania F (2023) Long-term effects of subthalamic nucleus deep brain stimulation on speech in parkinson\u2019s disease. Sci Rep 13:11462. https:\/\/doi.org\/10.1038\/s41598-023-38555-2","journal-title":"Sci Rep"},{"key":"8420_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/mds.21482","volume":"22","author":"P Piboolnurak","year":"2007","unstructured":"Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon Y-YW, Hutchison WD, Dostrovsky JO, Moro E (2007) Levodopa response in long-term bilateral subthalamic stimulation for parkinson\u2019s disease. Mov Disord 22:990\u2013997. https:\/\/doi.org\/10.1002\/mds.21482","journal-title":"Mov Disord"},{"key":"8420_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00415-009-0076-2","volume":"256","author":"H Gervais-Bernard","year":"2009","unstructured":"Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, Broussolle E, Thobois S (2009) Bilateral subthalamic nucleus stimulation in advanced parkinson\u2019s disease: five year follow-up. J Neurol 256:225\u2013233. https:\/\/doi.org\/10.1007\/s00415-009-0076-2","journal-title":"J Neurol"},{"key":"8420_CR36","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/brain\/awq221","volume":"133","author":"A Fasano","year":"2010","unstructured":"Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A (2010) Motor and cognitive outcome in patients with parkinson\u2019s disease 8 years after subthalamic implants. Brain 133:2664\u20132676. https:\/\/doi.org\/10.1093\/brain\/awq221","journal-title":"Brain"},{"key":"8420_CR37","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/jnnp-2013-306907","volume":"85","author":"I Aviles-Olmos","year":"2014","unstructured":"Aviles-Olmos I, Kefalopoulou Z, Tripoliti E, Candelario J, Akram H, Martinez-Torres I, Jahanshahi M, Foltynie T, Hariz M, Zrinzo L, Limousin P (2014) Long-term outcome of subthalamic nucleus deep brain stimulation for parkinson\u2019s disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry 85:1419\u20131425. https:\/\/doi.org\/10.1136\/jnnp-2013-306907","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8420_CR38","doi-asserted-by":"publisher","unstructured":"Cavallieri F, GessaniA, Merlo A, Campanini I, Budriesi C, Fioravanti V, Di Rauso G, Feletti A, Damiano B, Scaltriti S,Guagnano N, Bardi E, Corni MG, Antonelli F, Cavalleri F, Molinari MA, Contardi S, Menozzi E,Puzzolante A, Vannozzi G, Bergamini E, Pavesi G, Fraix V, Meoni S, Fraternali A, Versari A,Lusuardi M, Biagini G, Pinto S, Moro E, Valzania F (2023) Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment. Eur J Neurol 30(7):1963-1972.\u00a0https:\/\/doi.org\/10.1111\/ene.15803","DOI":"10.1111\/ene.15803"},{"key":"8420_CR39","doi-asserted-by":"publisher","unstructured":"Ollivier T, Pinto S, Rolland AS,Cailliau E, Touzet G, Thobois S, Eusebio A, Hainque E, Rouaud T, Drapier S, Guehl D, Maltete D,Anheim M, Lagha Boukbiza O, Giordana C, Tir M, Hopes L, Hubsch C, Jarraya B, Marques A, BrefelC, Rascol O, Corvol JC, Benatru I, Defebvre L, Devos D, Moreau C (2025) French PREDISTIM study group. Parkinson's disease, speech and neurosurgery. Brain Behav 15(5):e70101. https:\/\/doi.org\/10.1002\/brb3.70101","DOI":"10.1002\/brb3.70101"},{"key":"8420_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jcomdis.2011.05.003","volume":"44","author":"J Spielman","year":"2011","unstructured":"Spielman J, Mahler L, Halpern A, Gilley P, Klepitskaya O, Ramig L (2011) Intensive voice treatment (LSVT\u00aeLOUD) for parkinson\u2019s disease following deep brain stimulation of the subthalamic nucleus. J Commun Disord 44:688\u2013700. https:\/\/doi.org\/10.1016\/j.jcomdis.2011.05.003","journal-title":"J Commun Disord"},{"key":"8420_CR41","doi-asserted-by":"publisher","first-page":"1010253","DOI":"10.3389\/fnins.2022.1010253","volume":"16","author":"JL Vitek","year":"2022","unstructured":"Vitek JL, Patriat R, Ingham L, Reich MM, Volkmann J, Harel N (2022) Lead location as a determinant of motor benefit in subthalamic nucleus deep brain stimulation for parkinson\u2019s disease. Front Neurosci 16:1010253. https:\/\/doi.org\/10.3389\/fnins.2022.1010253","journal-title":"Front Neurosci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08420-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08420-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08420-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:02:12Z","timestamp":1760983332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08420-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["8420"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08420-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work described here has been carried out in accordance with the Declaration of Helsinki. The institutional research centre authority of the Grenoble Alpes University Hospital approved the study protocol that was registered with clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT03528460) on May 17, 2018.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Several authors received funds from Boston Scientific (BS), Medtronic (MT) manufacturers of DBS equipment, for work not related to this study. These include VF receiving honoraria for lecturing (BS, MT); SC receiving grants and personal fees (BS, MT); AC receiving grants from MT and reimbursement of travel expenses (BS, MT); EM receiving honoraria from MT and funds from AbelsonTaylor, Ipsen and French Association for Parkinson\u2019s Disease. FC, FB, AZ, SM, AG, ES, PP, FV, AS, SP, have nothing to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"After a reasonable request, access to the data of this study might be granted by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}